Grow Canada! Starting August 24th, according to a new ruling announced by Health Canada, medical cannabis patients can officially grow their own medicine. This comes on the tail of a Federal Court ruling earlier this year striking down the patient grow ban.
For patients with a medical cannabis prescription, the new rules base the number of plants allowed on the amount of medicine required. Per gram of dried cannabis, a patient may grow 5 indoor plants or 2 outdoor plants. The difference comes with the expectation that outdoor grows will have larger yields of medicine per plant.
The rules also allow patients who cannot physically grow their own medicine to designate another person to grow it for them. This allowance comes with the stipulation that that person grows for no more than 2 people, themselves included.
This ruling by Health Canada puts them in compliance with the Federal Court order mandating that the government make medicinal marijuana more affordable and accessible to those who need it. Despite the need for more affordable access,
Despite the need for more affordable access, dispensaries, and compassionate care groups currently operate in a legal gray area. They could, and do, help, but remain unauthorized to legitimately meet patient needs.
Currently, the only authorized avenues for medical cannabis remain through one of 34 licensed suppliers. Those suppliers provide for some 70,000 clients, with the limited supply increasing the cost passed on to the patients.
Justice Minister Jody Wilson-Raybould spoke after testifying before the Commons justice committee, saying,
The regulations that were spoken today form part of the considerations that our task group on marijuana will consider.
Certainly how it is dispensed and how the process of legalizing marijuana will be considered fully and the legislation and the subsequent regulations will reflect that consideration.
That comes with the expectation of Trudeau’s full legalization next year. A wait, that many feel is too long. Canopy Growth Corporation, parent company of Tweed Inc., stated,
While we believe this is a short-term initiative, with a broader overhaul of cannabis policy expected in the coming months, it is still a setback for the advancement of sound cannabis policy and Canada’s global leadership in cannabis regulation.
Yet, under the new ruling, the only authorized place for patients to purchase plants or seeds remains through those same 34 licensed companies. CEO of Mettrum Health Corp. Michael Haines said he doesn’t think home growing will affect his bottom line.
Medicinal marijuana is an evolving industry in Canada. It is a time of change and as a leading licensed producer we see change as opportunity — and see any focus on medical cannabis by regulators as positive.
Positive because patients have to purchase from them either way. But the Canadian Pharmacists Association thinks the government didn’t go far enough to limit who can dispense seeds and plants. Their statement in response to the ruling decried the decision not to give them sole authority to control medical cannabis. They called for tighter control in order to:
limit the emergence of a grey market and protect the medical system against abuse by recreational users.
But all of these steps are paving the way for the government’s timeline of full cannabis legalization scheduled for 2017. Sorry, CPA, no monopoly for you.
What do you think about the new ruling? Will patients use the new freedoms to their full potential, or will the market remain largely unaffected? Tell us on social media or in the comments below.